ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth | Mutual Fund Performance | Mint
Active Stocks
Fri Feb 23 2024 15:58:13
  1. Tata Steel share price
  2. 145.50 -0.24%
  1. State Bank Of India share price
  2. 759.40 -0.86%
  1. HDFC Bank share price
  2. 1,420.90 0.08%
  1. NTPC share price
  2. 337.70 -0.54%
  1. ITC share price
  2. 411.60 -0.65%
Business News/Market/Market Stats/    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth

+
  • Equity
  • Sector - Healthcare
  • Rating N.A.
  • Plan
30.53 +0.09 (0.30%) NAV as on 23 Feb, 2024
  • 5D
  • 1M
  • 6M
  • 1Y
  • 5Y
  • MAX

Key Metrics

  • AUM (in Cr)3566.52
  • CAGR 63.48%
  • Exit Load1.00%
  • Expense ratio1.99%
  • CategoryEquity
  • Min Investment5000
  • Min SIP100
  • Launch Date2018-07-12

Morning Star Rating N.A.

Medium
Risk
Exceptional
Return

Asset Allocation

Holdings As On - 24 February 2024

  • Name
  • Value (Cr)
  • Holding %
View More

Risk & Volitility

  • Alpha 6.03%
  • Beta 0.94
  • Sharpe Ratio0.96
  • Std Deviation 14.60%
  • Tracking Error 5.21%

About Fund

To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.

 

The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth has an AUM of 3566.52 crores & has delivered CAGR of 25.67% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.99%. The minimum investment in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth is Rs 5000 and the minimum SIP is Rs 100.

 

As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.

 

The top holdings of the fund include Sun Pharmaceutical Industries, Dr Reddys Laboratories, Cipla & Lupin.

 

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs & Chemical Manufacturing.

 

Some of the similar funds are DSP Healthcare Fund Regular Growth, ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth, SBI Healthcare Opportunities Fund Regular Growth, Nippon India Pharma Fund - Growth, Mirae Asset Healthcare Fund Regular Growth. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth has a sharpe ratio of 0.96 & a standard deviation of 14.60%.

FAQs about ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth

According to the morning star rating ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth has a Medium risk & Exceptional return.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth is managed by Dharmesh Kakkad,Sharmila D’mello.
The expense ratio of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth is 1.99%.
The 5 year annualized return on ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth is 25.67% & it has generated 63.48% in the last 1 year.
The minimum investment in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth is 5000 Rs.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth has an AUM of 3566.52 crores.
Recommended For You